Oct 24 2022
The Centers for Disease Control and Prevention (CDC) approved two new booster shots by Pfizer-BioNTech and Moderna that take aim at the latest strains and variants of COVID-19. The bivalent formulations of the vaccines were approved for use as a single booster dose at least two months following primary or booster vaccination. The vaccines are …
Permanent link to this article: https://www.50plusmarketplacenews.com/454125/latest-news/cdc-approves-covid-19-booster-shots
Dec 08 2020
Moderna and Pfizer have reported excellent early results from vaccine clinical trials. Vaccines aren’t approved yet, and the rollout will take massive mobilization efforts. An independent safety and data monitoring board reported today that early results from the Moderna Phase 3 clinical trials show the company’s vaccine was 94.5% effective. That news followed equally positive …
Permanent link to this article: https://www.50plusmarketplacenews.com/375110/denver-metro-latest-news/uchealth-reports-covid-19-vaccine-trials-positive
Dec 02 2020
Moderna and Pfizer have reported excellent early results from vaccine clinical trials. Vaccines aren’t approved yet, and the rollout will take massive mobilization efforts. An independent safety and data monitoring board reported today that early results from the Moderna Phase 3 clinical trials show the company’s vaccine was 94.5% effective. That news followed equally positive …
Permanent link to this article: https://www.50plusmarketplacenews.com/374274/latest-news/uchealth-reports-two-covid-19-vaccine-trials-positive
